RT-LAMP Zika Virus Detection Using Isothermal Amplification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for Zika virus (ZIKV) infection are not sufficiently rapid or specific, especially in prenatal care settings, due to cross-reactivity with other flaviviruses and the need for RNA detection within the acute phase, which complicates definitive diagnosis and requires advanced equipment like thermal cyclers.
Innovation Solution
A reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay using a set of specific primers and a pH-sensitive indicator dye for ZIKV nucleic acid detection in biological samples, allowing for rapid and specific diagnosis without the need for temperature cycling equipment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If reverse transcription PCR (RT-PCR) is used for ZIKV RNA detection, then detection sensitivity and specificity are improved, but equipment complexity and operational difficulty increase due to requirement of thermal cyclers
Solution Approach 1:
The patent replaces the thermal cycler mechanical system with an isothermal amplification system using loop-mediated isothermal amplification (LAMP) and strand displacement amplification (SDA). These methods achieve nucleic acid amplification at a constant temperature (typically 60-65°C) without requiring temperature cycling, thereby eliminating the need for complex thermal cycler equipment while maintaining high detection sensitivity for ZIKV RNA
Solution Approach 2:
The patent changes the temperature parameter from cyclic variation (PCR) to constant isothermal conditions (LAMP/SDA). This parameter change simplifies the equipment requirements while maintaining amplification efficiency. The constant temperature condition allows the use of simpler heating blocks or water baths instead of complex thermal cyclers, resolving the contradiction between detection sensitivity and equipment complexity
2Ease of operation
If serological ELISA methods are used for ZIKV diagnosis, then ease of operation is improved, but diagnostic accuracy deteriorates due to cross-reactivity with other flaviviruses
Solution Approach 1:
The patent replaces antibody-based serological detection with nucleic acid-based isothermal amplification detection. By targeting specific ZIKV RNA sequences through LAMP and SDA methods, the system achieves high diagnostic accuracy that distinguishes ZIKV from other flaviviruses, eliminating cross-reactivity issues while maintaining operational simplicity through isothermal conditions and visual detection methods
Solution Approach 2:
The patent uses multiple specific primers targeting different regions of the ZIKV genome in the LAMP and SDA reactions. This segmentation of the target sequence into multiple specific binding sites enhances specificity and eliminates cross-reactivity with other flaviviruses, while the isothermal nature of the reaction maintains ease of operation
3Productivity
If rapid diagnostic assays are developed for prenatal care, then diagnosis speed is improved, but detection sensitivity may deteriorate due to limited sample volume and time constraints
Solution Approach 1:
The patent employs isothermal amplification methods (LAMP and SDA) that continuously amplify target nucleic acid sequences at constant temperature without interruption for temperature cycling. This continuous amplification process achieves high detection sensitivity even with limited sample volumes typically obtained in prenatal care settings, while completing the reaction within 30-60 minutes to maintain rapid diagnosis capability
Solution Approach 2:
The patent incorporates reverse transcription step before amplification in the RT-LAMP and RT-SDA methods, converting RNA to cDNA in advance. This preliminary action ensures that even low-copy viral RNA present in limited prenatal samples is efficiently converted and amplified, maintaining high detection sensitivity while keeping the overall process rapid and suitable for point-of-care settings
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The RT-LAMP assay enables sensitive and specific detection of ZIKV RNA in urine and serum samples, capable of detecting as few as one RNA copy per microliter, with minimal equipment requirements and high specificity, facilitating rapid diagnosis in clinical or field settings.
Implementation Method 1
reverse transcription loop-mediated isothermal amplification (RT-LAMP) reaction using a set of primers specific for ZIKV nucleic acid
Implementation Method 2
loop-mediated isothermal amplification (LAMP) developed by Notomi et al. (Nucleic Acids Res 28:E63, 2000) is a technique for the amplification of nucleic acid utilizing 4-6 primers designed to amplify the gene target through creation of stem-loop structures that aid in synthesizing new DNA by the polymerase
Implementation Method 3
The RT-LAMP reaction includes a pH sensitive indicator dye, such as a dye detectable in visible light
Data Source
AI summary
A highly sensitive and specific reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay to detect ZIKV nucleic acid in biological samples is described. The disclosed assay is capable of detecting as few as one RNA copy per μl and can be performed in a clinical or field setting with minimal equipment and technological expertise. Oligonucleotide primers and kits for detecting ZIKV nucleic acid are also described.